Developing a CD71-Targeting Probody™ Drug Conjugate (PDC) for Activity in Multiple Solid Tumor and Lymphoma Models and for Tolerability in Non-human Primates

Shweta Singh, Laura Serwer, Niharika Chauhan, Amy DuPage, Michael Krimm, Ken Wong, Yuanhui Huang, Andrew Jang, Eric Ureno, Adam Miller, Sarah Patrick, Shanti Duvur, Fritz Buchanan, Matthew Ravn, Rob Leanna, Ilaria Badagnani, Tracy Henriques, Shouchun Liu, Luc Desnoyers, Claus Krebber, Sridhar Viswanathan, Jennifer Richardson, Susan Morgan-Lappe and W. Michael Kavanaugh. Poster presented at AACR-NCI-EORTC International Conference on Molecular Targets 2017, October 26-30, Philadelphia, Pennsylvania.